Shareholding disclosure

Diego Mortillaro

Declared position

8.66%

Threshold

Crossed upwards

Timeline

Published

30.01.2020

Transaction

23.01.2020

Transfer date

27.01.2020

Voting rights breakdown

Voting rights acquired8.66%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAK1S00075

Beneficial owner

Diego Mortillaro

Declared address

Diego Mortillaro, Milano

Reducing the total number of shares below the 10% threshold

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Diego Mortillaro

IGEA Pharma N.V.30.01.2020TAK1S00075

Disclosure summary

Diego Mortillaro disclosed a holding in IGEA Pharma N.V. on the acquisition side, published by SIX Exchange Regulation on 30.01.2020, at 8.66% of voting rights. Notice category: Single shareholder.

Disclosed position

8.66%

Voting rights acquired

Voting rights acquired8.66%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Diego Mortillaro disclosed a holding in IGEA Pharma N.V., published on 30.01.2020.

Publication date30.01.2020

Transaction date23.01.2020

Transfer date27.01.2020

Issuing companyIGEA Pharma N.V.

Beneficial ownerDiego Mortillaro

Declared addressDiego Mortillaro, Milano

CategorySingle shareholder

Voting rights acquired8.66%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAK1S00075

Conditions

Reducing the total number of shares below the 10% threshold

Source: SIX Exchange Regulation · Publication date: 30.01.2020

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open